Meta-analysis of the efficacy and safety of rituximab in the treatment of primary Sjögren’s syndrome

Meta-analysis of the efficacy and safety of rituximab in the treatment of primary Sjögren’s syndrome

ObjectiveTo methodically assess the effectiveness and safety of rituximab in treating primary Sjögren’s syndrome.MethodsThe search included databases such as PubMed, Embase, the Cochrane Library, and Web of Science, covering the period from the beginning until December 2023. A meta-analysis was cond...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiao Zheng, Jiaoyang Di, Xuexiao Chen, Fang Li, Yixuan Liu, Jingjing Cao, Xiaoran Ning, Lin Wei, Guimin Zheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Immunology
Subjects:
efficacy
primary Sjögren’s syndrome
rituximab
safety
treatment
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1561214/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2025.1561214/full

Similar Items